Delivering Transparency and Accountability in the Cannabis Supply Chain — While Monitoring Safety, Efficacy, Social Equity, and Health Outcomes
Forian is a leading provider of seed-to-sale traceability software and patient registries, serving nine state governments while delivering unparalleled stability and security. We support states as they seek to responsibly establish and expand cannabis programs, ensuring full transparency and accountability across the supply chain, from seed-to-sale. Forian also provides unique value in our ability to track and deliver timely reporting on cannabis-related adverse effects. Additionally, Forian enables state governments to evaluate the therapeutic value and reduction in healthcare costs associated with cannabinoid-based therapeutics as alternatives to traditional ethical pharmaceutical products and healthcare services — all while monitoring social equity issues related to the distribution of licenses.
BioTrack: All-in-One Cannabis Tracking Software
BioTrack’s Government Traceability system is designed to enable governments to track cannabis cultivation, manufacturing, testing, transportation, destruction, and sale to patients and customers. The primary objective is to ensure public safety through transparency and accountability and facilitating compliance. Regulators are provided with a patient portal that can be used to manage, approve, and print program applications and patient ID cards. Currently, we hold nine active government contracts.
Cannalytics: Business Intelligence Tool
A sophisticated SaaS business intelligence tool, Cannalytics provides interactive and actionable views of a state’s cannabis operations, including sales revenue and tax forecasting, inventory management, and cannabis consumer insights and trends (e.g., demographics, psychographics, behaviors, product loyalty, health conditions, and social determinants). Forian leverages one of the largest integrated cannabis databases in the industry and can provide states with benchmarks and market comparisons, industry growth projections, tax forecasting, product usage by differing demographic and healthcare condition cohorts, and insights on key industry trends.
A relationship with Forian helps governments champion and sustain a well-regulated cannabis environment.
Data Management Solutions
Forian has built technologies that address and solve the challenges created by the lack of uniform data standards and interoperability, delivering a coherent and uniform view for state regulators. Our leading-edge data management methodologies — including our novel and proprietary product master/ontology — normalize, standardize, deduplicate, integrate, and otherwise organize complex cannabis information to create state data standards for analytics and reporting, from seed-to-sale and beyond.
Real World Evidence (RWE)
Our proprietary data sets and enhanced patient registries enable states to evaluate the safety, efficacy, and social and health outcomes associated with cannabinoid usage among their populations. By contextualizing clinical evidence in real-world settings, we enable regulators to surveil for adverse events, quantify healthcare benefits, and determine the impacts on social equity issues from cannabis usage. Collectively, these analytics inform the creation and modification of public policy.
Forian understands the power of Real World Data (RWD). We build patient registries that capture richly detailed case information — coupling medical, pharmacy, consumer, cannabis utilization data, and patient-reported outcomes — to drive observational studies and Health Economics and Outcomes Research (HEOR), all while maintaining strict patient privacy and HIPAA compliance.
Forian provides innovative software solutions, proprietary data, and predictive analytics to optimize the operational, clinical, and financial performance of our healthcare, cannabis, and government customers.
41 University Drive
Newtown, PA 18940